# Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)

> **NCT00324662** · PHASE4 · COMPLETED · sponsor: **Biotronik SE & Co. KG** · enrollment: 260 (estimated)

## Conditions studied

- Tachyarrhythmia

## Interventions

- **DEVICE:** Implantable cardioverter-defibrillator

## Key facts

- **NCT ID:** NCT00324662
- **Lead sponsor:** Biotronik SE & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2008-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324662, "Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00324662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*